🆕#Breakpoints Episode: Drs. Erica Stohs, Ryan Stevens, & Jame McCrae join Dr. Megan Klatt to discuss AS practices at TOC & in the outpatient setting. Learn how to establish programs in this space, best practices for data/reporting & other tips for AS. 🎧 sidp.pinecast.co

【A narrative review on antimicrobial dosing in adult critically ill patients on ECMO】Critical Care, Oct 2, 2024 👉Congrats to our 2nd-year fellow, MJ, Adi, and team Mayo Clinic Infectious Diseases! 👉Comprehensive review of ECMO literature on pharmacokinetics and pharmacodynamics of

Candida guilliermondii is an uncommon cause of invasive candidiasis. Attached is a review of isolates from our institution. Around 20% of isolates non-wild type for fluconazole. Most cases in ICH, often HAI. Breakpoints needed for azoles Adi tinyurl.com/y5c3kymj

We're excited to host our next quarterly webinar on Thursday, November 14th. Melissa Johnson (Melissa Johnson) from DASON will be presenting on Antifungal Stewardship. Interested in joining? Message us at [email protected] with your contact info.

Fatal borealpox in an immunosuppressed patient treated with antivirals and vaccinia immunoglobulin -- Alaska, 2023 ✅ Just Accepted 🔗 bit.ly/48H8ynn

journals.asm.org/doi/10.1128/jc…

#ScholarlySunday features Dr. MJ Kim and her work on antimicrobial dosing in adults on ECMO. Congratulations MJ and to your collaborators and mentorship team! @IDDocAdi

Well done Dan Ilges and team. Mayo Clinic Infectious Diseases

A study led by Dr. Dan Ilges Ilges, at Mayo Clinic Arizona found that excluding #Cdifficile from gastrointestinal pathogen panels reduced unnecessary treatments, improved diagnostic accuracy, and caused no delays in diagnosis. Read more: contagionlive.com/view/excluding…

Systematic Review and Meta-Analysis of Audit and Feedback in Primary Care: 💊11% ⬇️prescribing volume ▶️23%⬇️in unnecessary initiation 💣17% ⬇️in broad-spectrum selection 🗓️13%⬇️in prolonged duration doi.org/10.1093/cid/ci… Great work by Kevin Schwartz and team JPIAMR

Publication Alert Machine Learning shows promise for enhancing OPAT outcomes by predicting adverse events and enabling pre-emptive interventions. @dwchallener Abinash Virk Madiha Fida doi.org/10.1093/jac/dk…

Only a few days left to submit an application - happy to answer any questions!

Pharmacy preceptors to resident research mentees over the next 3 months: “How are you going to finish all that data collecti….” Residents: x.com/DamnThatsInter…

Excited to share our State-of-the-Art Review: Complexities in CIED Infections: A Contemporary Practical Approch - published today in Clinical Infectious Diseases academic.oup.com/cid/article/80… Mayo Clinic Infectious Diseases LBaddour

Small study, but super interesting findings! SNAP might provide more info! 🆕️✨️Impact of Hypoalbuminemia on Clinical Outcomes in Patients Receiving Cefazolin for MSSA Bacteremia #idxposts journals.sagepub.com/doi/abs/10.117…

New manuscript in Journal of Infectious Diseases - we report a concerning rise in fluconazole resistance in Candida parapsilosis bloodstream isolates at our (referral) lab over the past several years. Consider susceptibility testing prior to transitioning to fluconazole. academic.oup.com/jid/advance-ar…

What's Hot in Infectious Diseases Pharmacology 2025 | Mayo Clinic School of Continuous Professional Development | CME Course Conference ce.mayo.edu/pharmacology/c…

🆕💫Retrospective cohort study Patients with first episode ceftriaxone-R Enterobacterales BSI had significantly greater prior antibiotic exposure than patients with ceftriaxone-S BSI and experienced significant delay of appropriate therapy #IDXposts academic.oup.com/cid/article-ab…

Very excited to publish our experience with MSCSF here at Mayo Clinic. Couldn’t have been possible without all the hardworking people at Mayo Clinic Labs, the guidance of my mentors Prof. Robin Patel omar abu saleh and my amazing co-fellow Sofia Molina!